Simplify Logo

Full-Time

Senior Program Manager

Posted on 6/24/2024

Element Biosciences

Element Biosciences

201-500 employees

Biotechnology firm specializing in DNA sequencing

Biotechnology

Compensation Overview

$149k - $189kAnnually

+ Stock Options + Bonus + Health Insurance + 401k

Senior, Expert

San Diego, CA, USA

This role will be an in-person, San Diego based role.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • BS in Engineering or Life Science discipline with 7+ years of relevant experience in complex scientific instrument product development (life sciences, biotechnology or medical device industries preferred)
  • Proven track record as a technical program manager leading commercial product development in a multidisciplinary environment
  • Ability to hold team members accountable for deliverables while maintaining strong, constructive interpersonal relationships with diverse stakeholders
  • Track record of successfully collaborating with other program teams, external partners and executives
  • Strong motivational, analytical, delegation and problem-solving skills
  • Proactive decision maker who understands how to assess and mitigate risk
  • Ability to lead effectively in a fast-paced and interdisciplinary technical environment
  • Proficient with project management tools and software (eg: MS Project, LucidChart, JIRA)
  • Experience in molecular diagnostics or genomic product development preferred
  • Experience with commercialization of clinical diagnostic or similar regulated products is beneficial
  • Experience in high-growth start-up companies is a plus
Responsibilities
  • Plan and execute development programs spanning the product lifecycle from concept to commercialization
  • Ensure program charter and product requirements are clear, grounded in customer needs and aligned with strategic business objectives
  • Build and execute integrated project plans synthesizing work breakdown structure, timeline, resource loading, budget and risk management
  • Create and manage a comprehensive program schedule that includes deliverables, milestones, dependencies and contingency plans
  • Assemble and lead project teams while deploying effective project management practices
  • Lead programs through a dynamic phase gate process ensuring that decisions are informed by a balanced and transparent representation of the relevant program data
  • Provide ongoing assessment of progress toward meeting performance, quality, timeline and cost targets
  • Apply decision analysis tools to analyze changing circumstances, offering pragmatic recommendations for adapting to and overcoming challenges
  • Mentor program team staff and contribute to performance reviews
  • Establish technical project management best practices and drive implementation of those methodologies across the company to improve the product development process

Element Biosciences specializes in next-generation sequencing (NGS) technology, primarily through its product, the AVITI System. This compact benchtop system provides high-quality DNA sequencing at a low cost, charging only $1 per million reads, which is significantly less than the industry average. The AVITI System is designed to deliver industry-leading accuracy, allowing users, including academic researchers and pharmaceutical companies, to maximize their resources. Element Biosciences differentiates itself from competitors by forming partnerships with other biotech firms, such as QIAGEN, to offer complete NGS workflows, enhancing the value of their product. Additionally, the company runs the 2023 AVITI for All Grant program, which provides free sequencing services for various applications, promoting research and demonstrating the capabilities of the AVITI System. The goal of Element Biosciences is to make high-quality sequencing accessible and affordable for a wide range of users.

Company Stage

Series C

Total Funding

$414M

Headquarters

San Diego, California

Founded

2017

Growth & Insights
Headcount

6 month growth

10%

1 year growth

14%

2 year growth

26%
Simplify Jobs

Simplify's Take

What believers are saying

  • Element Biosciences' recent $277M Series D funding round underscores strong investor confidence and provides substantial resources for growth and innovation.
  • The rapid growth in AVITI System installations, from 20 to over 150 units in a year, indicates strong market adoption and customer satisfaction.
  • The introduction of AVITI24 and Trinity platforms positions Element Biosciences at the forefront of multi-omics and targeted sequencing, potentially revolutionizing research capabilities.

What critics are saying

  • The competitive landscape in NGS technology is intense, with established players potentially overshadowing Element Biosciences' market presence.
  • Rapid expansion and scaling may strain operational capabilities and affect product quality or customer support.

What makes Element Biosciences unique

  • Element Biosciences offers the AVITI System, which provides high-quality sequencing at a significantly lower cost than industry standards, making advanced sequencing more accessible.
  • Strategic partnerships with companies like QIAGEN and Twist Bioscience enhance the AVITI System's capabilities, offering comprehensive NGS workflows and exome sequencing solutions.
  • The company's grant program, AVITI for All, democratizes access to sequencing technology, showcasing the system's capabilities and fostering innovation across various fields.

Help us improve and share your feedback! Did you find this helpful?

Benefits

100% company-paid medical, dental, & vision coverage

Flexible spending & health savings accounts

Premier mental health care

401(k) with immediately vested 4% company match

Company-paid Life and AD&D insurance

Stock option grants

Flexible time off

10 paid annual holidays

8-weeks paid parental leave

INACTIVE